Opal Therapeutics

San Francisco, US · 1 known investors

Opal Therapeutics develops organoid models and therapies centered on female biology to improve drug discovery outcomes in women's health. The company addresses the underserved space of female-specific drug development by building human-relevant models that better capture female biological characteristics.